| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
| ||||||||||||||||||||||||||||||||
a Departments of Medicine (Divisions of Cardiology, Case Western Reserve University, Cleveland, Ohio
b Departments of Medicine (Divisions of Clinical Pharmacology), Case Western Reserve University, Cleveland, Ohio
c Departments of Medicine (Divisions of Pharmacology, Case Western Reserve University, Cleveland, Ohio
d Departments of Medicine (Divisions of Chemistry, Case Western Reserve University, Cleveland, Ohio
e Medical Services and Geriatric Research, Education and Clinical Center, Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio
Edward J. Lesnefsky, Cardiology Section/Medical Service 111B(W), Louis Stokes Veterans Affairs Medical Center, 10701 East Boulevard, Cleveland, OH 44106 E-mail: EXL9{at}po.cwru.edu.
Decision Editor: John Faulkner, PhD
Aging selectively decreases the rate of oxidative phosphorylation in the interfibrillar population of cardiac mitochondria (IFM) located between the myofibers. In contrast, subsarcolemmal mitochondria (SSM), located below the plasma membrane, remain unaffected. IFM from elderly (24-month-old) Fischer 344 rats have a decreased specific activity of complexes III and IV. Complexes III and IV require an inner mitochondrial membrane lipid environment enriched in the oxidatively sensitive phospholipid cardiolipin for maximal activity. We asked if aging decreases the content or alters the composition of cardiolipin as a potential mechanism of the aging defect in IFM. The content and composition of mitochondrial phospholipids were measured in SSM and IFM from adult and aging rat hearts. Aging did not alter the content of mitochondrial phospholipids, including cardiolipin, in either population of mitochondria. The composition of cardiolipin based on characterization of both acyl group and the individual molecular species of cardiolipin was also unaltered by aging. Lipid-mediated oxidative modification of complex III subunits was not detected, making cardiolipin-derived oxidative damage to complex III unlikely. Thus, alterations in cardiolipin are not the mechanism for the aging defect in IFM in Fischer 344 rats.
This article has been cited by other articles:
![]() |
T. Nguyen, M. Ogbi, and J. A. Johnson Delta Protein Kinase C Interacts with the d Subunit of the F1F0 ATPase in Neonatal Cardiac Myocytes Exposed to Hypoxia or Phorbol Ester: IMPLICATIONS FOR F1F0 ATPase REGULATION J. Biol. Chem., October 31, 2008; 283(44): 29831 - 29840. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Rennison, T. A. McElfresh, I. C. Okere, H. V. Patel, A. B. Foster, K. K. Patel, M. S. Stoll, P. E. Minkler, H. Fujioka, B. D. Hoit, et al. Enhanced acyl-CoA dehydrogenase activity is associated with improved mitochondrial and contractile function in heart failure Cardiovasc Res, July 15, 2008; 79(2): 331 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen, S. Moghaddas, C. L. Hoppel, and E. J. Lesnefsky Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria Am J Physiol Cell Physiol, February 1, 2008; 294(2): C460 - C466. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Bray, C. A. Shaw, M. W. S. Moore, R. A. P. Garcia, M. M. Zanquetta, D. J. Durgan, W. J. Jeong, J.-Y. Tsai, H. Bugger, D. Zhang, et al. Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H1036 - H1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tanaka-Esposito, Q. Chen, S. Moghaddas, and E. J. Lesnefsky Ischemic preconditioning does not protect via blockade of electron transport J Appl Physiol, August 1, 2007; 103(2): 623 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Sparagna, A. J. Chicco, R. C. Murphy, M. R. Bristow, C. A. Johnson, M. L. Rees, M. L. Maxey, S. A. McCune, and R. L. Moore Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure J. Lipid Res., July 1, 2007; 48(7): 1559 - 1570. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. King, M. E. Young, J. Kerner, H. Huang, K. M. O'Shea, S. E. H. Alexson, C. L. Hoppel, and W. C. Stanley Diabetes or peroxisome proliferator-activated receptor {alpha} agonist increases mitochondrial thioesterase I activity in heart J. Lipid Res., July 1, 2007; 48(7): 1511 - 1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Judge and C. Leeuwenburgh Cardiac mitochondrial bioenergetics, oxidative stress, and aging Am J Physiol Cell Physiol, June 1, 2007; 292(6): C1983 - C1992. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Rennison, T. A. McElfresh, I. C. Okere, E. J. Vazquez, H. V. Patel, A. B. Foster, K. K. Patel, Q. Chen, B. D. Hoit, K.-Y. Tserng, et al. High-fat diet postinfarction enhances mitochondrial function and does not exacerbate left ventricular dysfunction Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1498 - H1506. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Chicco and G. C. Sparagna Role of cardiolipin alterations in mitochondrial dysfunction and disease Am J Physiol Cell Physiol, January 1, 2007; 292(1): C33 - C44. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen, A. K. S. Camara, D. F. Stowe, C. L. Hoppel, and E. J. Lesnefsky Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion Am J Physiol Cell Physiol, January 1, 2007; 292(1): C137 - C147. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ahmadzadeh, D. Andreyev, E. A. Arriaga, and L. V. Thompson Capillary Electrophoresis Reveals Changes in Individual Mitochondrial Particles Associated With Skeletal Muscle Fiber Type and Age J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2006; 61(12): 1211 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Lesnefsky, D. He, S. Moghaddas, and C. L. Hoppel Reversal of mitochondrial defects before ischemia protects the aged heart FASEB J, July 1, 2006; 20(9): 1543 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen, C. L. Hoppel, and E. J. Lesnefsky Blockade of Electron Transport before Cardiac Ischemia with the Reversible Inhibitor Amobarbital Protects Rat Heart Mitochondria J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 200 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Chandler, J. Kerner, H. Huang, E. Vazquez, A. Reszko, W. Z. Martini, C. L. Hoppel, M. Imai, S. Rastogi, H. N. Sabbah, et al. Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1538 - H1543. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Drew, S. Phaneuf, A. Dirks, C. Selman, R. Gredilla, A. Lezza, G. Barja, and C. Leeuwenburgh Effects of aging and caloric restriction on mitochondrial energy production in gastrocnemius muscle and heart Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R474 - R480. [Abstract] [Full Text] [PDF] |
||||
| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|